Choroidal Neovascularization
"Choroidal Neovascularization" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A pathological process consisting of the formation of new blood vessels in the CHOROID.
| Descriptor ID |
D020256
|
| MeSH Number(s) |
C11.941.160.244 C23.550.589.500.145
|
| Concept/Terms |
Choroidal Neovascularization- Choroidal Neovascularization
- Neovascularization, Choroid
- Neovascularization, Choroidal
- Choroidal Neovascularizations
- Choroid Neovascularization
- Choroid Neovascularizations
|
Below are MeSH descriptors whose meaning is more general than "Choroidal Neovascularization".
Below are MeSH descriptors whose meaning is more specific than "Choroidal Neovascularization".
This graph shows the total number of publications written about "Choroidal Neovascularization" by people in this website by year, and whether "Choroidal Neovascularization" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 1 | 0 | 1 |
| 2007 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
| 2016 | 3 | 0 | 3 |
| 2017 | 19 | 2 | 21 |
| 2018 | 15 | 3 | 18 |
| 2019 | 4 | 1 | 5 |
| 2020 | 2 | 0 | 2 |
| 2022 | 2 | 0 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Choroidal Neovascularization" by people in Profiles.
-
MULTIMODAL IMAGING AND TREATMENT OF SYPHILITIC CHOROIDAL NEOVASCULARIZATION. Retin Cases Brief Rep. 2022 Jan 01; 16(1):85-88.
-
CHOROIDAL NEOVASCULARIZATION ASSOCIATED WITH LONG-CHAIN 3-HYDROXYACYL-CoA DEHYDROGENASE DEFICIENCY. Retin Cases Brief Rep. 2022 Jan 01; 16(1):99-101.
-
OUTCOMES IN PATIENTS RESUMING INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOLLOWING TREATMENT DELAY DURING THE CORONAVIRUS-19 PANDEMIC. Retina. 2021 12 01; 41(12):2456-2461.
-
Ophthalmology and COVID-19: The Impact of the Pandemic on Patient Care and Outcomes: An IRIS® Registry Study. Ophthalmology. 2021 12; 128(12):1782-1784.
-
IMPACT OF CORONAVIRUS DISEASE PANDEMIC ON INTRAVITREAL INJECTIONS TREATMENT FOR MACULAR DISEASES: Report From a Referral Hospital in Milan. Retina. 2021 04 01; 41(4):701-705.
-
Short-term outcomes of patients with neovascular exudative AMD: the effect of COVID-19 pandemic. Graefes Arch Clin Exp Ophthalmol. 2020 Dec; 258(12):2621-2628.
-
Anti-vascular endothelial growth factor treatment regimens preference by choroidal neovascularization patients under COVID-19. Indian J Ophthalmol. 2020 10; 68(10):2314-2315.
-
Macula service evaluation and assessing priorities for anti-VEGF treatment in the light of COVID-19. Graefes Arch Clin Exp Ophthalmol. 2020 Dec; 258(12):2639-2645.
-
Increased Number of Submacular Hemorrhages as a Consequence of Coronavirus Disease 2019 Lockdown. Ophthalmol Retina. 2020 12; 4(12):1209-1210.
-
HIGHLIGHTS OF ADVANCES IN MEDICAL RETINA FROM THE VIRTUAL WORLD OPHTHALMOLOGY CONGRESS 2020. Cesk Slov Oftalmol. 2020; 76(5):227-230.